FindTrial
Sign In

Clinical Characteristics and Outcome of Patients With COPD With Pneumonia

Study on the Clinical Characteristics and Outcome of Patients With COPD Combined With Pneumonia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04966026
Enrollment
143
Registered
2021-07-19
Start date
2017-03-01
Completion date
2018-05-30
Last updated
2021-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Pneumonia

Brief summary

To identify the clinical characteristics of patients with chronic obstructive pulmonary disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing clinical transition.

Detailed description

To identify the clinical characteristics of patients with chronic obstructive pulmonary disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing clinical transition.Compared to other chronic airway diseases, COPD patients can often have CAP in combination, but there is a lack of comparative studies between COPD patients with CAP and non-COPD patients with CAP.

Interventions

OTHERNo inervention

No inervention

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. CAP meets the diagnostic criteria published in 2016 Chinese CAP diagnosis and treatment guidelines; CPOPD and AECOPD meet the diagnostic criteria published in Chinese 2013 COPD diagnosis and treatment guidelines; 2. Age ≧ 40years.

Exclusion criteria

1. age \<40years; 2. pregnancy; 3. positive for human immunodeficiency virus (HIV) antibodies; 4. suspected or confirmed tuberculosis or fungal infection of the lung.

Design outcomes

Primary

MeasureTime frameDescription
mortality rateDay 28 from hospitalizationmortality rate

Secondary

MeasureTime frameDescription
cause of using antimicrobial drugsthrough study completion, an average of 1 yearDays of using antimicrobial drugs during hospitalization
hospital feesthrough study completion, an average of 1 yearhospital fees.
Number of days in hospitalthrough study completion, an average of 1 yearNumber of days in hospital
number of days in ICUthrough study completion, an average of 1 yearnumber of days in ICU
number of days on mechanical ventilationthrough study completion, an average of 1 yearnumber of days on mechanical ventilation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026